Refine
Has Fulltext
- yes (16)
Is part of the Bibliography
- yes (16)
Document Type
- Journal article (16)
Language
- English (16)
Keywords
- ischemic stroke (4)
- biomarker (3)
- cardiovascular events (3)
- chronic cerebrovascular disease (2)
- mortality (2)
- Amino acids (1)
- Clinical-trials (1)
- Cumulative incidence function (1)
- Fabry nephropathy (1)
- Fabry patient (1)
- Family Investigation of Nephropathy and Diabetes (1)
- Haemodialysis (1)
- Hazards (1)
- Heart failure (1)
- Homoarginine (1)
- L-arginine (1)
- LDL cholesterol (1)
- LV mass (1)
- Model (1)
- Probabilities (1)
- Regression (1)
- Sample-sizes (1)
- Subdistribution (1)
- Sudden cardiac death (1)
- Tests (1)
- activated receptor-1 (1)
- acute ischemic stroke (1)
- aldosterone (1)
- alkaline phosphatase (1)
- atherosclerosis (1)
- biocompatibility (1)
- biomarkers (1)
- blood (1)
- blood coagulability (1)
- cardiac hypertrophy (1)
- cardiomyopathy (1)
- cardiovascular disease (1)
- cerebrovascular diseases (1)
- chronic kidney disease (1)
- cornea verticillata (1)
- cortisol (1)
- creatine synthesis (1)
- demography (1)
- diabetes (1)
- diabetic kidney disease (1)
- diabetic mouse (1)
- dialysis (1)
- enzyme replacement therapy (1)
- epidemiology (1)
- erythropoietin (1)
- fabry disease (1)
- factor XI (1)
- factor XII (1)
- factor-V-Leiden (1)
- fibroblast growth factor-23 (1)
- fractionation membranev (1)
- gene polymorphism (1)
- genome-wide association study (1)
- heart failure (1)
- hemodialysis (1)
- heodialysis patients (1)
- human brian endothelium (1)
- hypercholesterolemia (1)
- hypertrophic cardiomyopathy (1)
- immune cells (1)
- increased risk (1)
- induced insulin-release (1)
- kidney disease (1)
- left ventricular hypertrophy (1)
- left ventricular mass (1)
- leukocytes (1)
- lipoprotein apheresis (1)
- lipoprotein(a) (1)
- lymphocytes (1)
- mice impact (1)
- mineral metabolism (1)
- monocytes (1)
- myocardial fibrosis (1)
- nictric-oxide (1)
- organ dysfunktion (1)
- parathyroid hormone (1)
- phosphate homeostasis (1)
- platelets (1)
- polymorphisms inflammation (1)
- rat kidney (1)
- regulatory T cells (1)
- renal disease (1)
- renal fibrosis (1)
- renal function (1)
- risk (1)
- septal hypertrophy (1)
- severe sepsis (1)
- sex addiction (1)
- stroke (1)
- sudden cardiac death (1)
- thromboinflammation (1)
- troponin T (1)
- type 2 diabetes (1)
- urinary protein excretion (1)
- vascular access (1)
- venous thrombosis (1)
- von Willebrand factor (1)
Background:
Competing risks methodology allows for an event-specific analysis of the single components of composite time-to-event endpoints. A key feature of competing risks is that there are as many hazards as there are competing risks. This is not always well accounted for in the applied literature.
Methods:
We advocate a simulation point of view for understanding competing risks. The hazards are envisaged as momentary event forces. They jointly determine the event time. Their relative magnitude determines the event type. 'Empirical simulations' using data from a recent study on cardiovascular events in diabetes patients illustrate subsequent interpretation. The method avoids concerns on identifiability and plausibility known from the latent failure time approach.
Results:
The 'empirical simulations' served as a proof of concept. Additionally manipulating baseline hazards and treatment effects illustrated both scenarios that require greater care for interpretation and how the simulation point of view aids the interpretation. The simulation algorithm applied to real data also provides for a general tool for study planning.
Conclusions:
There are as many hazards as there are competing risks. All of them should be analysed. This includes estimation of baseline hazards. Study planning must equally account for these aspects.